v3.20.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Revenue        
Product revenue, net $ 9,415 $ 8,199 $ 21,361 $ 14,324
Revenue - related party 42 1,051 1,014 1,403
Net Revenue 9,457 9,250 22,375 15,727
Operating expenses        
Cost of goods sold - product revenue 3,124 2,386 6,934 4,270
Research and development 15,703 18,511 30,570 41,784
Research and development - licenses acquired 1,570 200 1,820 650
General and administrative 14,456 13,443 29,975 26,921
Total operating expenses 34,853 34,540 69,299 73,625
Loss from operations (25,396) (25,290) (46,924) (57,898)
Other income (expense)        
Interest income 336 779 963 1,217
Interest expense and financing fee (3,059) (3,106) (6,184) (5,575)
Change in fair value of derivative liability (344)   (386)  
Gain on deconsolidation of Caelum   137   18,521
Total other income (expense) (3,067) (2,190) (5,607) 14,163
Net loss (28,463) (27,480) (52,531) (43,735)
Less: net loss attributable to non-controlling interests 15,149 14,382 26,847 32,029
Net loss attributable to common stockholders $ (13,314) $ (13,098) $ (25,684) $ (11,706)
Net loss per common share - basic and diluted $ (0.42) $ (0.51) $ (0.80) $ (0.86)
Net loss per common share attributable to non - controlling interests - basic and diluted (0.22) (0.27) (0.41) (0.63)
Net loss per common share attributable to common stockholders - basic and diluted $ (0.19) $ (0.24) $ (0.39) $ (0.23)
Weighted average common shares outstanding - basic and diluted 68,550,494 53,726,125 66,023,367 51,130,977

Source